---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-22-000718"
form_type: "8-K"
ticker: "CDIO"
cik: "0001870144"
company_name: "Cardio Diagnostics Holdings, Inc."
filed_at: "2022-05-31T23:59:59+00:00"
generated_at: "2026-06-25T06:01:24.578835+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Mana Capital SPAC to merge with Cardio Diagnostics in deal valuing target at $75M base

## Summary
- Cardio stockholders to receive shares of Mana Capital common stock valued at $10.00/share; base consideration $75M.
- Additional earnout up to 1M shares if stock price reaches $12.50, $15.00, $17.50, $20.00 thresholds.
- Closing conditions include Mana stockholder approval, Nasdaq listing, minimum $5M net tangible assets, and $4.5M private placement.
- Expected closing Q3/Q4 2022; outside date Dec 23, 2022; Cardio pays $3M breakup fee in certain termination scenarios.
- Post-closing board: six directors designated by Cardio, one by Mana; executive officers become Cardio's officers.

## SEC filing metadata
- accession: 0001079973-22-000718
- form_type: 8-K
- ticker: CDIO
- cik: 0001870144
- company_name: Cardio Diagnostics Holdings, Inc.
- filed_at: 2022-05-31T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870144/000107997322000718/0001079973-22-000718-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870144/000107997322000718/mana_8k-052722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-22-000718
- JSON: https://secwatch.observer/filing/0001079973-22-000718.json
- Plain text: https://secwatch.observer/filing/0001079973-22-000718.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.